Skip to main content
Log in

Prothrombin complex concentrate for off-label use: 3- vs 4-factor

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • DeAngelo J, et al. Comparison of blood product use and costs with use of 3-factor versus 4-factor prothrombin complex concentrate for off-label indications. American Journal of Health-System Pharmacy : 25 Jun 2018. Available from: URL: http://doi.org/10.2146/ajhp180076

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prothrombin complex concentrate for off-label use: 3- vs 4-factor. PharmacoEcon Outcomes News 807, 29 (2018). https://doi.org/10.1007/s40274-018-5108-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5108-7

Navigation